Test Price
2,800 AED✅ Home Collection Available
SNRPE Gene Hypotrichosis Type 11 Genetic Test in UAE
Executive Summary & Core Metrics
The SNRPE Gene Hypotrichosis Type 11 Genetic Test employs Next Generation Sequencing (NGS) to identify pathogenic variants within the SNRPE gene, delivering a diagnostic sensitivity of 99.9% for hereditary hypotrichosis type 11. This molecular analysis provides definitive confirmation for dermatologists, anti-aging specialists, and medical geneticists, enabling targeted therapeutic planning. The service includes VIP mobile phlebotomy with temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM, a comprehensive post-test telephonic consultation with a genetic counselor, and direct insurance coverage verification via WhatsApp at +971545488731.
Test Overview & Methodology
This genetic test utilizes high-throughput Next Generation Sequencing to analyze the full coding region and splice sites of the SNRPE gene. NGS technology enables simultaneous detection of single nucleotide variants, small insertions and deletions, and copy number variations with 99.9% diagnostic accuracy. Compared to traditional Sanger sequencing, the NGS platform provides broader genomic coverage, higher sensitivity for mosaic variants, and a significantly faster turnaround time, making it the gold standard for hereditary hypotrichosis molecular diagnosis. A pre-test clinical consultation and pedigree analysis are recommended for optimal result interpretation.
Pre-test requirement: Clinical history and a genetic counseling session to construct a family pedigree chart documenting affected individuals with SNRPE gene-related hypotrichosis type 11.
| Feature | Our NGS Test | Traditional Sanger Sequencing |
|---|---|---|
| Methodology | High‑throughput NGS (full gene coverage) | Limited to specific exons |
| Diagnostic Sensitivity | 99.9% | ~90% |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Sample Types | Blood, Extracted DNA, FTA Card | Blood only |
| Cost‑Effectiveness | Comprehensive single test (2800 AED) | Higher cumulative cost if multiple exons tested |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I recognize the profound impact that a definitive molecular diagnosis has on both patient management and family counseling. This NGS-based test delivers precise identification of SNRPE gene variants, empowering clinicians to offer tailored therapeutic strategies and informed recurrence risk assessment. The results must always be correlated with clinical findings and interpreted within the broader context of the patient’s medical and family history.” — Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or modify any prescribed medications prior to or following the genetic test without explicit consultation with your treating physician. The test result does not replace ongoing clinical management or pharmacotherapy decisions.
Patient Exclusion Criteria & Emergency Red Flags
- Minors: Written parental or legal guardian consent is mandatory for all patients under 18 years of age per UAE Federal Law No. 2 of 2019.
- Active systemic infection or severe coagulopathy: Alternative collection arrangements or a delayed draw may be clinically advised to ensure patient safety.
- Post-draw emergency: Seek immediate medical attention at the nearest emergency department if you experience excessive bleeding, expanding hematoma, severe pain, or signs of infection at the venipuncture site.
Patient FAQ & Clinical Guidance
1. What is the purpose of the SNRPE gene test and who should consider it?
The SNRPE Genetic Test detects disease-causing mutations associated with hypotrichosis type 11, offering 99.9% diagnostic sensitivity for a definitive molecular diagnosis. It is recommended for individuals with a family history of early-onset hereditary hair loss, patients with clinical features suggestive of hypotrichosis type 11, and dermatology or anti-aging specialists seeking to confirm a genetic etiology before initiating targeted therapy.
2. How is the sample collected and what is the turnaround time?
Sample collection is performed via standard venous blood draw, a dried blood spot on an FTA card, or submission of previously extracted high-quality DNA. Our premium VIP mobile phlebotomy service operates daily from 8 AM to 11 PM, utilizing ISO-certified temperature-controlled cold-chain logistics for specimen transport to the laboratory. Results are reported within 3 to 4 weeks, ensuring both clinical accuracy and timely decision-making.
3. Is the test covered by UAE health insurance and what privacy protections are in place?
Many UAE health insurance providers extend coverage for genetic diagnostic testing; contact our dedicated billing team via WhatsApp at +971 54 548 8731 for direct verification of your policy benefits and out-of-pocket obligations. All patient data, including genetic sequence information, is processed and stored under the strict confidentiality requirements of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019, ensuring your genomic privacy is fully safeguarded.
4. What clinical preparation is required before the test?
A pre-test genetic counseling session is strongly advised to review the patient's personal and family history, construct a three-generation pedigree, and discuss the potential implications of test results. No fasting or special dietary preparation is required. The patient should bring any available medical records, previous dermatological assessments, and family photographs documenting the pattern of hair loss.
UAE Regulatory & Data Privacy Adherence
This genetic testing service operates in full compliance with the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring that all patient genomic data and personal identifiers are processed lawfully, stored securely, and accessed only by authorized personnel. Additionally, the laboratory adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, which governs the handling of electronic health records and telemedicine services. Clinical safety and patient consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing transparent communication and ethical care throughout the diagnostic pathway. The laboratory is ISO 9001:2015 certified (INT/EGQ/2509DA/3139) and holds full DHA licensure for molecular genetic testing.
Clinical & Logistical Metadata
| Test Name | SNRPE Gene Hypotrichosis Type 11 Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene coverage |
| ICD-10-CM Code | Q84.0 |
| LOINC Code | 94247-3 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians